Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 27.32%10.99B | 27.26%2.73B | 29.67%2.53B | 18.35%8.63B | 23.80%2.32B | 22.67%2.21B | 15.71%2.15B | 10.89%1.95B | 33.99%7.3B | 24.27%1.88B |
Cost of revenue | 30.29%3.12B | 47.54%828.67M | 30.37%695.77M | 24.31%2.4B | 36.37%626.02M | 34.83%675.49M | 14.00%561.67M | 12.29%533.69M | 32.85%1.93B | 14.64%459.07M |
Gross profit | 26.18%7.87B | 20.08%1.9B | 29.41%1.84B | 16.20%6.24B | 19.73%1.7B | 17.99%1.54B | 16.33%1.59B | 10.37%1.42B | 34.40%5.37B | 27.74%1.42B |
Operating expense | 6.89%7.61B | 8.46%1.79B | 18.90%1.86B | 13.90%7.12B | 21.86%2.03B | 14.81%1.87B | 10.90%1.65B | 6.86%1.57B | 63.48%6.25B | 43.57%1.67B |
Operating profit | 129.60%260.92M | 287.05%116.59M | 82.09%-26.44M | 0.13%-881.42M | -34.05%-333.29M | -2.28%-338.15M | 49.29%-62.33M | 18.14%-147.65M | -617.26%-882.54M | -388.98%-248.64M |
Net non-operating interest income (expenses) | -1.58%-20.56M | 61.84%-2.29M | 21.83%-4.73M | 25.79%-20.24M | 30.09%-4.43M | 41.73%-3.76M | 14.35%-6M | 19.11%-6.05M | -102.32%-27.27M | -129.38%-6.34M |
Non-operating interest income | 146.67%518K | -11.29%55K | -13.04%40K | -13.93%210K | -17.14%58K | -10.20%44K | -16.22%62K | -9.80%46K | 454.55%244K | 133.33%70K |
Non-operating interest expense | 3.07%21.08M | -61.32%2.34M | -21.77%4.77M | -25.69%20.45M | -29.95%4.49M | -41.49%3.81M | -14.37%6.06M | -19.04%6.09M | 103.47%27.52M | 129.42%6.41M |
Net investment income | 104.22%569K | -230,400.00%-11.52M | -49.24%7.27M | 77.00%-13.5M | 69.39%-2.13M | -16.85%-25.69M | 100.02%5K | 296.22%14.32M | -1,200.73%-58.68M | -6.97M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 88.53%-6.22M | -289.39%-54.26M | 39.24%-8.47M | 0 | 80.17%-13.93M | -13.93M | ||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 86.48%-153.18M | -16,023.49%-1.13B | -109.12%-7.03M | |||||||
Less:Write off | -86.48%153.18M | ---- | ---- | 16,023.49%1.13B | ---- | ---- | ---- | ---- | --7.03M | ---- |
Other non-operating income (expenses) | -143.73%-56.51M | -12.54%-14.32M | -75,300.00%-3.77M | -54.43%-23.19M | -395.52%-6.75M | 63.06%-3.71M | -419.44%-12.72M | 99.57%-5K | 94.22%-15.02M | 97.81%-1.36M |
Income before tax | 101.18%25.01M | 166.85%84.79M | 80.15%-27.67M | -111.63%-2.13B | -423.53%-1.49B | -0.60%-371.32M | 18.06%-126.84M | 28.99%-139.38M | -901.24%-1B | -547.73%-284.27M |
Income tax | -1,399.33%-202.15M | 285.05%25.16M | 2,038.55%23.52M | 253.59%15.56M | 112.40%2.33M | 408.45%5.59M | 492.48%6.54M | 0.00%1.1M | -30.47%4.4M | -68.44%1.1M |
Net income | 110.61%227.16M | 144.70%59.62M | 63.56%-51.19M | -112.25%-2.14B | -422.33%-1.49B | -1.81%-376.91M | 14.45%-133.37M | 28.83%-140.48M | -845.96%-1.01B | -502.51%-285.37M |
Net income continuous operations | 110.61%227.16M | 144.70%59.62M | 63.56%-51.19M | -112.25%-2.14B | -422.33%-1.49B | -1.81%-376.91M | 14.45%-133.37M | 28.83%-140.48M | -845.96%-1.01B | -502.51%-285.37M |
Noncontrolling interests | -186.08%-93.57M | -299.78%-10.7M | -202.50%-34.96M | 58.11%-32.71M | 5.00%-29.87M | 110.05%3.36M | 896.14%5.36M | 8.19%-11.56M | -78.09M | -31.44M |
Net income attributable to the company | 115.21%320.73M | 150.69%70.33M | 87.41%-16.23M | -126.54%-2.11B | -475.24%-1.46B | -12.90%-380.26M | 10.63%-138.73M | 30.24%-128.93M | -772.74%-930.78M | -436.13%-253.93M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 115.21%320.73M | 150.69%70.33M | 87.41%-16.23M | -126.54%-2.11B | -475.24%-1.46B | -12.90%-380.26M | 10.63%-138.73M | 30.24%-128.93M | -772.74%-930.78M | -436.13%-253.93M |
Gross dividend payment | ||||||||||
Basic earnings per share | 114.86%8.01 | 149.86%1.77 | 87.69%-0.41 | -121.89%-53.92 | -467.17%-37.32 | -10.45%-9.72 | 12.35%-3.55 | 31.62%-3.33 | -749.65%-24.3 | -422.22%-6.58 |
Diluted earnings per share | 114.56%7.85 | 149.20%1.7465 | 87.69%-0.41 | -121.89%-53.92 | -467.17%-37.32 | -10.45%-9.72 | 12.35%-3.55 | 31.62%-3.33 | -749.65%-24.3 | -422.22%-6.58 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |